4 Results for "

OVCAR4

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "OVCAR4" in MCE Product Catalog:

Cat. No.: HY-143293
CAS No.: 2874264-13-6
Target:  

VEGFR Apoptosis

Research Areas:  

Cancer

VEGFR-IN-3 (compound 3f) is a VEGFR inhibitor. VEGFR-IN-3 inhibits OVCAR-4 and MDA-MB-468 cancer cells growth with IC50s of 0.29 and 0.35 μM, respectively. VEGFR-IN-3 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-151588
CAS No.: 2977251-03-7
Target:  

Virus Protease

Research Areas:  

Cancer

Anticancer agent 90 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor activity. Anticancer agent 90 has high inhibition against the two cell line from ovarian cancer (OVCAR-4), renal cancer (A498) .
loading...
    loading...
Cat. No.: HY-151587
CAS No.: 2977251-05-9
Target:  

Others

Research Areas:  

Cancer

Anticancer agent 89 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor activity, has high inhibition against the three cell line from ovarian cancer (OVCAR-4), renal cancer (A498), and melanoma (SK-MEL-5) .
loading...
    loading...
Cat. No.: HY-D3186
CAS No.: 2163840-29-5
HMRef-βGal is a fluorescent probe and a substrate responsive to β-galactosidase (β-galactosidase) (Ex/Em=498 nm/505-600 nm). After being cleaved by β-galactosidase, HMRef-βGal triggers significant fluorescence enhancement via intramolecular spirocyclic function regulation. HMRef-βGal generates bright fluorescence in cancer cells with elevated β-galactosidase activity, enabling visualization of tiny peritoneal metastases in mouse models. HMRef-βGal exhibits low in vitro cytotoxicity and low acute in vivo toxicity in mice. HMRef-βGal can be used for preclinical fluorescence-guided diagnosis and cytoreductive surgery of peritoneal metastases, including compatibility with real-time naked-eye detection and endoscopic imaging, as well as for studies related to peritoneal metastases of ovarian cancer .
loading...
    loading...